Agilent Technologies (A) Goodwill: History & Chart

Agilent Technologies, Inc.(A)

Medical - Diagnostics & Research · Santa Clara, CA

$144.78+0.00 (+0.00%)

Delayed quote: Sep 9, 2026, 3:59 PM EDT

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Santa Clara, CA

18,000 employees

www.agilent.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Padraig McDonnell

View full financials

Goodwill

The latest quarterly goodwill is $5.03 Billion. Goodwill is an intangible asset recorded when a company acquires another business for more than the fair value of its identifiable net assets.

Acquisitions|PP&E|Total Assets|Net Income|Balance Sheet

Goodwill

A Goodwill

$5.03B

Reported quarterly goodwill; no daily interpolation. Quarter ended Jul 2026 (2026-07-31): $5.03B.

+99.84% over 10Y

Current Goodwill

$5.03B

$5.03 Billion

QoQ Growth

N/A

Historical Data

Quarters of data available

Quarterly Goodwill History

Period	Goodwill	QoQ Growth	YoY Growth
Quarter ended Jul 2026Period end 2026-07-31	$5.03B	N/A	N/A
Quarter ended Apr 2026Period end 2026-04-30	$4.48B	N/A	N/A
Quarter ended Jan 2026Period end 2026-01-31	$4.48B	N/A	N/A
Quarter ended Oct 2025Period end 2025-10-31	$4.47B	N/A	N/A
Quarter ended Jul 2025Period end 2025-07-31	$4.47B	N/A	N/A
Quarter ended Apr 2025Period end 2025-04-30	$4.47B	N/A	N/A
Quarter ended Jan 2025Period end 2025-01-31	$4.43B	N/A	N/A
Quarter ended Oct 2024Period end 2024-10-31	$4.48B	N/A	N/A
Quarter ended Jul 2024Period end 2024-07-31	$3.96B	N/A	N/A
Quarter ended Apr 2024Period end 2024-04-30	$3.96B	N/A	N/A
Quarter ended Jan 2024Period end 2024-01-31	$3.97B	N/A	N/A
Quarter ended Oct 2023Period end 2023-10-31	$3.96B	N/A	N/A
Quarter ended Jul 2023Period end 2023-07-31	$3.98B	N/A	N/A
Quarter ended Apr 2023Period end 2023-04-30	$3.98B	N/A	N/A
Quarter ended Jan 2023Period end 2023-01-31	$3.98B	N/A	N/A
Quarter ended Oct 2022Period end 2022-10-31	$3.95B	N/A	N/A
Quarter ended Jul 2022Period end 2022-07-31	$3.95B	N/A	N/A
Quarter ended Apr 2022Period end 2022-04-30	$3.96B	N/A	N/A
Quarter ended Jan 2022Period end 2022-01-31	$3.96B	N/A	N/A
Quarter ended Oct 2021Period end 2021-10-31	$3.98B	N/A	N/A
Quarter ended Jul 2021Period end 2021-07-31	$3.98B	N/A	N/A
Quarter ended Apr 2021Period end 2021-04-30	$4.05B	N/A	N/A
Quarter ended Jan 2021Period end 2021-01-31	$3.62B	N/A	N/A
Quarter ended Oct 2020Period end 2020-10-31	$3.60B	N/A	N/A
Quarter ended Jul 2020Period end 2020-07-31	$3.61B	N/A	N/A
Quarter ended Apr 2020Period end 2020-04-30	$3.58B	N/A	N/A
Quarter ended Jan 2020Period end 2020-01-31	$3.59B	N/A	N/A
Quarter ended Oct 2019Period end 2019-10-31	$3.59B	N/A	N/A
Quarter ended Jul 2019Period end 2019-07-31	$3.11B	N/A	N/A
Quarter ended Apr 2019Period end 2019-04-30	$3.11B	N/A	N/A
Quarter ended Jan 2019Period end 2019-01-31	$3.13B	N/A	N/A
Quarter ended Oct 2018Period end 2018-10-31	$2.97B	N/A	N/A
Quarter ended Jul 2018Period end 2018-07-31	$2.93B	N/A	N/A
Quarter ended Apr 2018Period end 2018-04-30	$2.62B	N/A	N/A
Quarter ended Jan 2018Period end 2018-01-31	$2.63B	N/A	N/A
Quarter ended Oct 2017Period end 2017-10-31	$2.61B	N/A	N/A
Quarter ended Jul 2017Period end 2017-07-31	$2.61B	N/A	N/A
Quarter ended Apr 2017Period end 2017-04-30	$2.57B	N/A	N/A
Quarter ended Jan 2017Period end 2017-01-31	$2.56B	N/A	N/A
Quarter ended Oct 2016Period end 2016-10-31	$2.52B	N/A	N/A
Quarter ended Jul 2016Period end 2016-07-31	$2.52B	N/A	N/A
Quarter ended Apr 2016Period end 2016-04-30	$2.56B	N/A	N/A
Quarter ended Jan 2016Period end 2016-01-31	$2.48B	N/A	N/A
Quarter ended Oct 2015Period end 2015-10-31	$2.37B	N/A	N/A
Quarter ended Jul 2015Period end 2015-07-31	$2.37B	N/A	N/A
Quarter ended Apr 2015Period end 2015-04-30	$2.34B	N/A	N/A
Quarter ended Jan 2015Period end 2015-01-31	$2.35B	N/A	N/A
Quarter ended Oct 2014Period end 2014-10-31	$2.51B	N/A	N/A
Quarter ended Jul 2014Period end 2014-07-31	$3.01B	N/A	N/A
Quarter ended Apr 2014Period end 2014-04-30	$3.07B	N/A	N/A
Quarter ended Jan 2014Period end 2014-01-31	$3.02B	N/A	N/A
Quarter ended Oct 2013Period end 2013-10-31	$3.05B	N/A	N/A
Quarter ended Jul 2013Period end 2013-07-31	$3.00B	N/A	N/A
Quarter ended Apr 2013Period end 2013-04-30	$3.01B	N/A	N/A
Quarter ended Jan 2013Period end 2013-01-31	$3.07B	N/A	N/A
Quarter ended Oct 2012Period end 2012-10-31	$3.02B	N/A	N/A
Quarter ended Jul 2012Period end 2012-07-31	$2.95B	N/A	N/A
Quarter ended Apr 2012Period end 2012-04-30	$1.60B	N/A	N/A
Quarter ended Jan 2012Period end 2012-01-31	$1.60B	N/A	N/A
Quarter ended Oct 2011Period end 2011-10-31	$1.57B	N/A	N/A
Quarter ended Jul 2011Period end 2011-07-31	$1.58B	N/A	N/A
Quarter ended Apr 2011Period end 2011-04-30	$1.55B	N/A	N/A
Quarter ended Jan 2011Period end 2011-01-31	$1.45B	N/A	N/A
Quarter ended Oct 2010Period end 2010-10-31	$1.46B	N/A	N/A
Quarter ended Jul 2010Period end 2010-07-31	$1.40B	N/A	N/A
Quarter ended Apr 2010Period end 2010-04-30	$644.00M	N/A	N/A
Quarter ended Jan 2010Period end 2010-01-31	$657.00M	N/A	N/A
Quarter ended Oct 2009Period end 2009-10-31	$655.00M	N/A	N/A
Quarter ended Jul 2009Period end 2009-07-31	$642.00M	N/A	N/A
Quarter ended Apr 2009Period end 2009-04-30	$648.00M	N/A	N/A
Quarter ended Jan 2009Period end 2009-01-31	$666.00M	N/A	N/A
Quarter ended Oct 2008Period end 2008-10-31	$646.00M	N/A	N/A
Quarter ended Jul 2008Period end 2008-07-31	$642.00M	N/A	N/A
Quarter ended Apr 2008Period end 2008-04-30	$630.00M	N/A	N/A
Quarter ended Jan 2008Period end 2008-01-31	$605.00M	N/A	N/A
Quarter ended Oct 2007Period end 2007-10-31	$736.00M	N/A	N/A
Quarter ended Jul 2007Period end 2007-07-31	$0	N/A	N/A
Quarter ended Apr 2007Period end 2007-04-30	$517.00M	N/A	N/A
Quarter ended Jan 2007Period end 2007-01-31	$517.00M	N/A	N/A
Quarter ended Oct 2006Period end 2006-10-31	$385.00M	N/A	N/A
Quarter ended Jul 2006Period end 2006-07-31	$395.00M	N/A	N/A
Quarter ended Apr 2006Period end 2006-04-30	$481.00M	N/A	N/A
Quarter ended Jan 2006Period end 2006-01-31	$0	N/A	N/A
Quarter ended Oct 2005Period end 2005-10-31	$0	N/A	N/A
Quarter ended Jul 2005Period end 2005-07-31	$0	N/A	N/A
Quarter ended Apr 2005Period end 2005-04-30	$0	N/A	N/A
Quarter ended Jan 2005Period end 2005-01-31	$0	N/A	N/A
Quarter ended Oct 2004Period end 2004-10-31	$0	N/A	N/A
Quarter ended Jul 2004Period end 2004-07-31	$0	N/A	N/A
Quarter ended Apr 2004Period end 2004-04-30	$0	N/A	N/A
Quarter ended Jan 2004Period end 2004-01-31	$0	N/A	N/A
Quarter ended Oct 2003Period end 2003-10-31	$0	N/A	N/A
Quarter ended Jul 2003Period end 2003-07-31	$0	N/A	N/A
Quarter ended Apr 2003Period end 2003-04-30	$0	N/A	N/A
Quarter ended Jan 2003Period end 2003-01-31	$0	N/A	N/A
Quarter ended Oct 2002Period end 2002-10-31	$0	N/A	N/A

Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.

Data as of July 31, 2026

Goodwill

A Goodwill

Current Goodwill

QoQ Growth

Historical Data

Quarterly Goodwill History

Related Metrics